Skip to content

Effects of Homoeopathic Treatment in patients suffering from Leucorrhoea and/ or abnormal Vaginal discharge.

Comparing individualized homoeopathic treatment and placebo in patients of Chronic Cervicitis:A randomized double -blind placebo-control trial. - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055813
Enrollment
140
Registered
2023-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

Sponsors

The Calcutta Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Females suffering from vaginal discharges, and other manifestations of Chronic Cervicitis. 2)Chronic Cervicitis diagnosed with cervical cytology 3)Patients not undergoing regular oral/topical analgesics/NSAIDs therapy for acute episodes of cervicitis, or stopped completely for at least 1 month.

Exclusion criteria

Exclusion criteria: 1)Known malignant cases of Cervicitis. 2)Presence of abnormal findings in cervical PAPs smear, i.e., those patients having development of cervical malignancy. 3)Non-ambulant patients 4)Uncontrolled, unevaluated and/or complicated diabetes mellitus, hypertension, and other co-morbidities 5)Cases with other systemic unevaluated or uncontrolled diseases like cardiovascular, renal, gastro-intestinal, endocrinal, gynecological diseases etc. or systemic infections affecting quality of life or on other treatment therapies 6)Psychiatric illness. 7)Patients with any vital organ failure. 8)Recent pelvic surgery within last 6 months. 9)History of homeopathic treatment for any chronic disease within last 3 months 10)Self-reported immune-compromised states 11)Alcohol/drug addiction or dependence 12)Inability to comply with the study protocol

Design outcomes

Primary

MeasureTime frame
Vulvo-Vaginal symptoms score (VSQ)Timepoint: baseline & at one month interval for three months

Secondary

MeasureTime frame
EQ-5D-5L QuestionnaireTimepoint: baseline & at one month interval for three months

Countries

India

Contacts

Public ContactDr Debashis Biswas

The Calcutta Homoeopathic Medical College and hospital

drdebashisb4u@gmail.com8910487012

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026